S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:NTLA

Intellia Therapeutics SEC Filings & 10K Form

$113.13
-2.39 (-2.07%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$111.01
$117.95
50-Day Range
$113.13
$155.26
52-Week Range
$35.61
$202.73
Volume
494,494 shs
Average Volume
1.49 million shs
Market Capitalization
$8.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.03

Intellia Therapeutics (NASDAQ:NTLA) SEC Filings

DateFilerForm TypeView
09/01/2021
7:21 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
6:34 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
6:32 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
6:30 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2021
3:14 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
5:14 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
5:19 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
5:17 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2021
8:48 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2021
5:14 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
5:10 PM
Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
5:08 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
5:05 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
5:03 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
4:57 PM
Crowley John F (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
4:56 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2021
4:20 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
6:15 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2021
3:15 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2021
8:51 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
7:55 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
6:51 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
3:54 PM
Intellia Therapeutics (Filer)
Form DEFA14A
04/15/2021
7:50 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
3:37 PM
Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
3:35 PM
Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/12/2021
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2021
1:14 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
5:09 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
7:46 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
7:42 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:54 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:53 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:52 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:50 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:49 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:49 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
12:59 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
5:27 AM
Intellia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
6:42 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
3:24 PM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
02/09/2021
7:38 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:36 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
5:10 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
02/03/2021
8:39 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:38 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
3:59 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
01/22/2021
3:22 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
8:24 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:58 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:55 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
8:03 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:29 PM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
5:01 AM
Intellia Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
12/08/2020
3:26 PM
Intellia Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
12/03/2020
5:42 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:59 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
3:00 PM
Intellia Therapeutics (Filer)
Form 424B5
11/30/2020
4:06 PM
Intellia Therapeutics (Filer)
Form 424B5
11/30/2020
3:02 PM
Intellia Therapeutics (Filer)
Form S-3ASR
11/27/2020
8:00 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
7:02 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:56 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:55 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
6:54 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
3:41 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
3:38 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
8:01 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:56 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
7:05 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
7:58 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
3:14 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
3:55 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:15 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
7:23 AM
Intellia Therapeutics (Filer)
Form CT ORDER
08/20/2020
3:30 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
08/20/2020
3:13 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:29 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:18 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:10 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:13 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:54 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2020
3:47 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:46 PM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:45 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:44 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
3:44 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:00 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:18 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:21 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2020
4:14 PM
Intellia Therapeutics (Filer)
Form 424B5
06/01/2020
3:52 PM
Intellia Therapeutics (Filer)
Form 424B5
06/01/2020
6:13 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
4:23 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.